Terig Hughes

Part of VolitionRX Ltd., Singapore Volition Pte Ltd. provides diagnostic services for cancer patients. Singapore Volition was acquired by Standard Capital Corp. on October 07, 2011 for $0.07 million.

Part of AUM Biosciences Ltd., AUM Biosciences Pte Ltd. is a clinical-stage biotech company based in Singapore, Singapore. The Singaporean company focuses on discovering and developing novel targeted oncology therapies, particularly for cancers with a clear genetic marker. AUM Biosciences has an extensive track record of selecting distinctive early-stage assets, successfully exiting virtual biotech models, and contributing significantly to the development of several currently marketed oncology treatments with annual peak sales up to $3 billion. AUM Biosciences is advancing a broad portfolio of precision oncology therapeutics, including AUM001, AUM601, and AUM302, which have entered clinical trials and received orphan drug designation from the FDA for the treatment of various cancers. The company was founded by Harish Dave and is currently led by CEO Vishal Doshi.

RELX Group Plc engages in the provision of information and analytics for professional and business customers. It operates in four major segments such as scientific, technical and medical, risk and business analytics, legal and exhibitions. The company was founded on September 11, 1992 and is headquartered in London, the United Kingdom.

Elsevier, Inc. publishes journals, online materials, and books. It offers Scopus, ScienceDirect, Mendeley, Evolve, Knovel, Reaxys and ClinicalKey. The company is headquartered in Newton, MA.